Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis

Abstract Background Neutrophil to lymphocyte ratio (NLR), as a recent inflammatory index, has been reported to be a prognostic tool in different diseases. However, implication of this ratio in heart failure (HF) is less investigated. In this systematic review and meta-analysis, we aimed to assess th...

Full description

Bibliographic Details
Main Authors: Mehrbod Vakhshoori, Sepehr Nemati, Sadeq Sabouhi, Behzad Yavari, Mehrnaz Shakarami, Niloofar Bondariyan, Sayed Ali Emami, Davood Shafie
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-023-03572-6
_version_ 1797578272455786496
author Mehrbod Vakhshoori
Sepehr Nemati
Sadeq Sabouhi
Behzad Yavari
Mehrnaz Shakarami
Niloofar Bondariyan
Sayed Ali Emami
Davood Shafie
author_facet Mehrbod Vakhshoori
Sepehr Nemati
Sadeq Sabouhi
Behzad Yavari
Mehrnaz Shakarami
Niloofar Bondariyan
Sayed Ali Emami
Davood Shafie
author_sort Mehrbod Vakhshoori
collection DOAJ
description Abstract Background Neutrophil to lymphocyte ratio (NLR), as a recent inflammatory index, has been reported to be a prognostic tool in different diseases. However, implication of this ratio in heart failure (HF) is less investigated. In this systematic review and meta-analysis, we aimed to assess the potential impact of NLR on HF clinical outcomes. Methods Relevant English published records in PubMed, Scopus, Embase, and Web of Science were screened up to July 2023. Articles reporting clinical outcomes (follow-up or in-hospital mortality, readmission, HF prediction, extended hospital stay length, pulmonary vascular resistance, atrial fibrillation, renal disease and functional capacity) in HF sufferers were collected for further analysis with addition of NLR difference stratified by death/survived and HF status. Results Thirty-six articles (n = 18231) were finally selected which reported NLR in HF sufferers (mean: 4.38, 95% confidence interval (CI): 4.02–4.73). We found 25 articles reported NLR and total mortality (either follow-up death (N = 19): 4.52 (95% CI: 4.03–5.01) or in-hospital death (N = 10): 5.33 (95% CI: 4.08–6.57)) with mean NLR of 4.74 (95% CI: 4.28–5.20). NLR was higher among deceased patients compared to survived ones (standard mean difference: 0.67 (95% CI: 0.48–0.87), P < 0.001)). NLR was found to be related with higher mortality risk (continuous variable: hazard ratio (HR): 1.12, 95% CI: 1.02–1.23, P = 0.013), categorical variable: HR: 1.77, 95% CI: 1.27–2.46, P = 0.001, T2 vs. T1: HR:1.56, 95%CI: 1.21–2.00, P = 0.001, T3 vs. T1: HR:2.49, 95%CI: 1.85–3.35, P < 0.001). Other aforementioned variables were not feasible to analyze due to presence of few studies. Conclusions NLR is a simple and acceptable prognostic tool for risk stratification and prioritizing high risk patients in clinical settings, especially in resource limited nations.
first_indexed 2024-03-10T22:20:36Z
format Article
id doaj.art-b958d18199f14725805997c429b61c91
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-03-10T22:20:36Z
publishDate 2023-11-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-b958d18199f14725805997c429b61c912023-11-19T12:18:26ZengBMCBMC Cardiovascular Disorders1471-22612023-11-0123112210.1186/s12872-023-03572-6Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysisMehrbod Vakhshoori0Sepehr Nemati1Sadeq Sabouhi2Behzad Yavari3Mehrnaz Shakarami4Niloofar Bondariyan5Sayed Ali Emami6Davood Shafie7Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical SciencesSchool of Medicine, Tehran Azad University of Medical SciencesStudent Research Committee, School of Medicine, Isfahan University of Medical SciencesCardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical SciencesHeart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical SciencesDepartment of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical SciencesHeart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical SciencesHeart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical SciencesAbstract Background Neutrophil to lymphocyte ratio (NLR), as a recent inflammatory index, has been reported to be a prognostic tool in different diseases. However, implication of this ratio in heart failure (HF) is less investigated. In this systematic review and meta-analysis, we aimed to assess the potential impact of NLR on HF clinical outcomes. Methods Relevant English published records in PubMed, Scopus, Embase, and Web of Science were screened up to July 2023. Articles reporting clinical outcomes (follow-up or in-hospital mortality, readmission, HF prediction, extended hospital stay length, pulmonary vascular resistance, atrial fibrillation, renal disease and functional capacity) in HF sufferers were collected for further analysis with addition of NLR difference stratified by death/survived and HF status. Results Thirty-six articles (n = 18231) were finally selected which reported NLR in HF sufferers (mean: 4.38, 95% confidence interval (CI): 4.02–4.73). We found 25 articles reported NLR and total mortality (either follow-up death (N = 19): 4.52 (95% CI: 4.03–5.01) or in-hospital death (N = 10): 5.33 (95% CI: 4.08–6.57)) with mean NLR of 4.74 (95% CI: 4.28–5.20). NLR was higher among deceased patients compared to survived ones (standard mean difference: 0.67 (95% CI: 0.48–0.87), P < 0.001)). NLR was found to be related with higher mortality risk (continuous variable: hazard ratio (HR): 1.12, 95% CI: 1.02–1.23, P = 0.013), categorical variable: HR: 1.77, 95% CI: 1.27–2.46, P = 0.001, T2 vs. T1: HR:1.56, 95%CI: 1.21–2.00, P = 0.001, T3 vs. T1: HR:2.49, 95%CI: 1.85–3.35, P < 0.001). Other aforementioned variables were not feasible to analyze due to presence of few studies. Conclusions NLR is a simple and acceptable prognostic tool for risk stratification and prioritizing high risk patients in clinical settings, especially in resource limited nations.https://doi.org/10.1186/s12872-023-03572-6Neutrophil to lymphocyte ratioHeart failurePrognosisMortalitySystematic reviewMeta-analysis
spellingShingle Mehrbod Vakhshoori
Sepehr Nemati
Sadeq Sabouhi
Behzad Yavari
Mehrnaz Shakarami
Niloofar Bondariyan
Sayed Ali Emami
Davood Shafie
Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis
BMC Cardiovascular Disorders
Neutrophil to lymphocyte ratio
Heart failure
Prognosis
Mortality
Systematic review
Meta-analysis
title Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis
title_full Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis
title_fullStr Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis
title_full_unstemmed Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis
title_short Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis
title_sort neutrophil to lymphocyte ratio nlr prognostic effects on heart failure a systematic review and meta analysis
topic Neutrophil to lymphocyte ratio
Heart failure
Prognosis
Mortality
Systematic review
Meta-analysis
url https://doi.org/10.1186/s12872-023-03572-6
work_keys_str_mv AT mehrbodvakhshoori neutrophiltolymphocyterationlrprognosticeffectsonheartfailureasystematicreviewandmetaanalysis
AT sepehrnemati neutrophiltolymphocyterationlrprognosticeffectsonheartfailureasystematicreviewandmetaanalysis
AT sadeqsabouhi neutrophiltolymphocyterationlrprognosticeffectsonheartfailureasystematicreviewandmetaanalysis
AT behzadyavari neutrophiltolymphocyterationlrprognosticeffectsonheartfailureasystematicreviewandmetaanalysis
AT mehrnazshakarami neutrophiltolymphocyterationlrprognosticeffectsonheartfailureasystematicreviewandmetaanalysis
AT niloofarbondariyan neutrophiltolymphocyterationlrprognosticeffectsonheartfailureasystematicreviewandmetaanalysis
AT sayedaliemami neutrophiltolymphocyterationlrprognosticeffectsonheartfailureasystematicreviewandmetaanalysis
AT davoodshafie neutrophiltolymphocyterationlrprognosticeffectsonheartfailureasystematicreviewandmetaanalysis